Luca Sala

Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of ≥ 50%

Alessio Cortellini, Marcello Tiseo, Giuseppe Luigi Banna et al. · Cancer Immunology Immunotherapy · 2020 · 87 citations · Full text

Advanced Nsclc, Oncology, First-line Pembrolizumab Effectiveness +6

Immune-related Adverse Events of Pembrolizumab in a Large Real-world Cohort of Patients With NSCLC With a PD-L1 Expression ≥ 50% and Their Relationship With Clinical Outcomes

Alessio Cortellini, Alex Friedlaender, Giuseppe Luigi Banna et al. · Clinical Lung Cancer · 2020 · 82 citations · Full text

Pd-l1 Expression, Clinical Epidemiology, Immunology +8

Follow-up of Oral Leukoplakia After Carbon Dioxide Laser Surgery

F. Chiesa, N Tradati, Luca Sala et al. · Archives of Otolaryngology - Head and Neck Surgery · 1990 · 70 citations

Clinical relevance of clonal hematopoiesis in persons aged ≥80 years

Marianna Rossi, Manja Meggendorfer, Matteo Zampini et al. · Blood · 2021 · 64 citations · Full text

Phase II study of high-dose epirubicin in non-small cell lung cancer

J. Wils, I Made Susila Utama, Luca Sala et al. · European Journal of Cancer and Clinical Oncology · 1990 · 35 citations

Oncology, Medicine, High-dose Epirubicin +7